Cover Image
市場調查報告書

Orchid Chemicals & Pharmaceuticals Ltd - 產品平台分析

Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 251700
出版日期 內容資訊 英文 42 Pages
訂單完成後即時交付
價格
Back to Top
Orchid Chemicals & Pharmaceuticals Ltd - 產品平台分析 Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2015
出版日期: 2015年10月21日 內容資訊: 英文 42 Pages
簡介

Orchid Chemicals & Pharmaceuticals Ltd 是特別致力於開發、製造心血管,抗糖尿病藥物,神經精神醫學,營養補充品領域製劑和原料藥的製藥公司。

本報告提供Orchid Chemicals & Pharmaceuticals Ltd 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Orchid Chemicals & Pharmaceuticals Ltd 基本資料

Orchid Chemicals & Pharmaceuticals Ltd 概要

  • 主要資訊
  • 企業資料

Orchid Chemicals & Pharmaceuticals Ltd :R&D概要

  • 主要的治療範圍

Orchid Chemicals & Pharmaceuticals Ltd :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Orchid Chemicals & Pharmaceuticals Ltd :開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Orchid Chemicals & Pharmaceuticals Ltd :藥物簡介▼OCID-4681

  • Orchid Chemicals & Pharmaceuticals Ltd OCID-0050
  • Orchid Chemicals & Pharmaceuticals Ltd OCID-2987
  • Orchid Chemicals & Pharmaceuticals Ltd OCID-5005
  • Orchid Chemicals & Pharmaceuticals Ltd OCID-5090
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecule to Inhibit Dipeptidyl-Peptidase IV for Type 2 Diabetes
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecule to Inhibit IL-6 and STAT3 for Oncology
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecule to Inhibit Th1/Th2 Cytokine Synthase for Inflammation
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecule to Inhibit TNF Alpha for Inflammation
  • Orchid Chemicals & Pharmaceuticals Ltd tubastatin
  • Orchid Chemicals & Pharmaceuticals Ltd cephalosporin
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecule 1 to Inhibit HDAC for Oncology
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecule 2 to Inhibit HDAC for Oncology
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecule 3 to Inhibit HDAC for Oncology
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecule for Central Nervous System
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecule for Diabetes
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecule for Obesity
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecule to Antagonize ALK for Lung Cancer
  • Orchid Chemicals & Pharmaceuticals Ltd Small Molecules for Tuberculosis

Orchid Chemicals & Pharmaceuticals 按Ltd :開發平台分析▼標的

  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Orchid Chemicals & Pharmaceuticals Ltd :暫停中的計劃

Orchid Chemicals & Pharmaceuticals Ltd :總公司和子公司的所地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07668CDB

Summary

Global Markets Direct's, 'Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2015', provides an overview of the Orchid Chemicals & Pharmaceuticals Ltd's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Orchid Chemicals & Pharmaceuticals Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Orchid Chemicals & Pharmaceuticals Ltd including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Orchid Chemicals & Pharmaceuticals Ltd's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Orchid Chemicals & Pharmaceuticals Ltd's pipeline products

Reasons to buy

  • Evaluate Orchid Chemicals & Pharmaceuticals Ltd's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Orchid Chemicals & Pharmaceuticals Ltd in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Orchid Chemicals & Pharmaceuticals Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Orchid Chemicals & Pharmaceuticals Ltd and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Orchid Chemicals & Pharmaceuticals Ltd
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Orchid Chemicals & Pharmaceuticals Ltd and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Orchid Chemicals & Pharmaceuticals Ltd Snapshot
    • Orchid Chemicals & Pharmaceuticals Ltd Overview
    • Key Information
    • Key Facts
  • Orchid Chemicals & Pharmaceuticals Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products Glance
    • Orchid Chemicals & Pharmaceuticals Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Orchid Chemicals & Pharmaceuticals Ltd - Drug Profiles
    • OCID-0050
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OCID-2987
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OCID-5005
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OCID-5090
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 3 to Inhibit HDAC for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Dipeptidyl-Peptidase IV for Type II Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit IL-6 and STAT3 for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Th1/Th2 Cytokine Synthase for Inflammation
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit TNF Alpha for Inflammation
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • tubastatin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 1 to Inhibit HDAC for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule 2 to Inhibit HDAC for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Central Nervous System
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Obesity
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Antagonize ALK for Lung Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Penicillin-Binding Proteins for Bacterial Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Tuberculosis
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Analysis
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Target
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Route of Administration
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Molecule Type
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Mechanism of Action
  • Orchid Chemicals & Pharmaceuticals Ltd - Dormant Projects
  • Orchid Chemicals & Pharmaceuticals Ltd - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Orchid Chemicals & Pharmaceuticals Ltd, Key Information
  • Orchid Chemicals & Pharmaceuticals Ltd, Key Facts
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Indication, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Stage of Development, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Monotherapy Products in Pipeline, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Out-Licensed Products in Pipeline, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Preclinical, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Discovery, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Target, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Route of Administration, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Molecule Type, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Mechanism of Action, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Dormant Developmental Projects,2015
  • Orchid Chemicals & Pharmaceuticals Ltd, Other Locations
  • Orchid Chemicals & Pharmaceuticals Ltd, Subsidiaries

List of Figures

  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Top 10 Indication, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Stage of Development, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Monotherapy Products in Pipeline, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Top 10 Target, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline by Top 10 Molecule Type, 2015
  • Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top